Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- PHASE2
Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
- Status
- COMPLETED
- Phase
- NA
First Line Ovarian Cancer Treatment - Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Abraxane/Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
- Status
- COMPLETED
- Phase
- N/A
PRevention of Macular EDema After Cataract Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)
- Status
- COMPLETED
- Phase
- PHASE2